|
|
Volumn 36, Issue 15, 2000, Pages 1905-1908
|
|
The impact of loco-regional radiotherapy on the survival of breast cancer patients. Arbiter.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BREAST TUMOR;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
FEMALE;
HUMAN;
LYMPH NODE METASTASIS;
MASTECTOMY;
META ANALYSIS;
METHODOLOGY;
MORTALITY;
MULTIMODALITY CANCER THERAPY;
NOTE;
RANDOMIZED CONTROLLED TRIAL;
RISK FACTOR;
TREATMENT OUTCOME;
TUMOR RECURRENCE;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BREAST NEOPLASMS;
COMBINED MODALITY THERAPY;
FEMALE;
HUMANS;
LYMPHATIC METASTASIS;
MASTECTOMY;
META-ANALYSIS;
NEOPLASM RECURRENCE, LOCAL;
RANDOMIZED CONTROLLED TRIALS;
RISK FACTORS;
TREATMENT OUTCOME;
|
|
EID: 0034296945
PISSN: 09598049
EISSN: None
Source Type: Journal
DOI: 10.1016/S0959-8049(00)00280-X Document Type: Article |
|
Times cited : (4)
|
|
References (11)
|
